SP

Saroj Pathak

Active Director Director DIN 07895788
DIN 07895788 First appointment Jul 2017 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2017
Shareholding value •••• Premium profile

About Saroj Pathak

Data last updated:

Saroj Pathak is a Director at Novelty Pharmaceuticals Private Limited (since 2017). The company operates in Chemicals. Novelty Pharmaceuticals Private Limited reported revenue of ₹6 Lakh (FY 2017).

DIN 07895788
Primary Designation Director
Industry Chemicals
First Appointment 15 Jul 2017
Oldest Company Age 14 yrs
Largest company Novelty Pharmaceuticals Private Limited · ₹6 Lakh (FY 2017)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Jul 20172012₹6 Lakh (FY 2017)Active

Board colleagues of Saroj Pathak

NameDINCompanyDesignation
Rama Sahu05292266Novelty Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Novelty Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Saroj Pathak

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Saroj Pathak

Saroj Pathak currently holds 1 directorship: Novelty Pharmaceuticals Private Limited (Director, since 15 Jul 2017, revenue ₹6 Lakh (FY 2017)).

Saroj Pathak was first appointed on 15 Jul 2017 as Director at Novelty Pharmaceuticals Private Limited.

The current boards of Saroj Pathak's companies include Rama Sahu (Novelty Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available